Maternal serum vitamin D level in early pregnancy and risk for preeclampsia: A case-control study in Southern Sweden
Open Access
- 7 February 2023
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (2) , e0281234
Abstract
Background: Preeclampsia is considered a major cause of maternal and fetal morbidity and mortality. The aim of the present case-control study in Sweden was to assess the hypothesized association between low serum vitamin D concentrations in early pregnancy and the risk of developing preeclampsia since vitamin D may play a role in early placental development. Methods: The study included 296 women diagnosed with preeclampsia (cases) and 580 healthy pregnant women (controls). Serum samples were obtained from a biobank of samples collected in early pregnancy including almost all pregnancies in Southern Sweden. Concentrations of 25-hydroxyvitamin D3 (vitamin D) were analyzed using liquid chromatography-tandem-mass-spectrometry (LC/MS/MS). The cases were divided into two categories: i) infants were born before gestational week 34 (early onset) and/or born small-for-gestational age (SGA)(n = 51), ii) and others defined as late onset (n = 245). Vitamin D concentrations were analyzed both as a continuous and a categorized variable. Results: When all preeclampsia cases were included in the analyses no consistent patterns were observed. However, the median serum concentrations of vitamin D were significantly lower among the cases who were early onset and/or were born SGA (median 39.2 nmol/L, range 1.2–93.6) as compared to the controls (49.0 nmol/L, 0.1–219; p = 0.01). In addition, high concentrations were statistically significantly associated with a decreased risk of preeclampsia (>66.9 vs ≤30.1 nmol/L; crude OR 0.39, 95% CI 0.16–0.96). When potential confounders were included in the models the associations were even more pronounced. Conclusions: Our results support the hypothesis that vitamin D deficiency is a risk factor for preeclampsia, but only in preeclampsia cases who were early-onset and/or were born SGA. Preeclampsia is not a homogenous condition and more studies are needed before vitamin D supplementation during pregnancy can be recommended.Keywords
Funding Information
- Swedish Research Council for Sustainable Development ((FORMAS, Dnr 217-00699))
- European Union, Interreg VÖKS (Dnr 2018-0075)
- Lund University
This publication has 30 references indexed in Scilit:
- Pre-Eclampsia and Future Cardiovascular Risk Among WomenJACC, 2014
- Epidemiology of preeclampsia: impact of obesityNutrition Reviews, 2013
- Vitamin D and Pre-Eclampsia: Original Data, Systematic Review and Meta-AnalysisAnnals of Nutrition and Metabolism, 2013
- A Nested Case-Control Study of Intrauterine Exposure to Persistent Organochlorine Pollutants and the Risk of HypospadiasPLOS ONE, 2012
- Impact of maternal characteristics on fetal growth in the third trimester: a population‐based studyUltrasound in Obstetrics & Gynecology, 2012
- Severe vitamin D deficiency in pregnant women of Somali origin living in SwedenActa Paediatrica, 2011
- Plasma 25-hydroxyvitamin D levels in early-onset severe preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2010
- Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysisBMJ, 2007
- Maternal Vitamin D Deficiency Increases the Risk of PreeclampsiaThe Journal of Clinical Endocrinology & Metabolism, 2007
- The Use of National Health Registers for Studying Environmental Causes of Congenital DefectsReviews on Environmental Health, 2005